PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer

PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer

Xinwei Li,1,* Yongfei Fan,2,* Mingyue Tang,1 Huiyuan Li,1 Yue Zhang,1 Jiaqi Mi,1 Yanyan Wang,1 Menglin Zhao,1 Zishu Wang,1 Fang Su1 1Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People’s Republic of China; 2Department of Thoraci...

Full description

Bibliographic Details
Main Authors: Li X, Fan Y, Tang M, Li H, Zhang Y, Mi J, Wang Y, Zhao M, Wang Z, Su F
Format: Article
Language:English
Published: Dove Medical Press 2022-09-01
Series:Journal of Inflammation Research
Subjects:
plxdc1
biomarker
tumor microenvironment
immune evasion
prognosis
immunotherapy
Online Access:https://www.dovepress.com/plxdc1-can-be-a-biomarker-for-poor-prognosis-and-immune-evasion-in-gas-peer-reviewed-fulltext-article-JIR

Internet

https://www.dovepress.com/plxdc1-can-be-a-biomarker-for-poor-prognosis-and-immune-evasion-in-gas-peer-reviewed-fulltext-article-JIR

Similar Items